Biodexa Pharmaceuticals

United Kingdom
Abingdon, England, United Kingdom, OX14 4RY

Company profile

Biodexa Pharmaceuticals company profile

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a commercial platform and four marketed products in the US. Midatech's strategy is to develop products in-house in oncology and with partners in other indications, and to accelerate growth organically and through strategic acquisitions.

Business identity

Contact email
[email protected]
Phone number
+44 1235 841575
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2000-01-01, Year

Headquarters

Postal code
OX14 4RY
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
10
Total equity funding
$91.7M
Last funding
Post IPO Equity / $10M / 2025-12-18
Last equity funding
Post IPO Equity / $10M
Investors
3
Lead investors
3
Articles
136
Exited on
2014-12-19

Founders and investors

Lead investors

Cancer Prevention and Research Institute of TexasC/M Capital PartnersIppon Capital

Investors

Cancer Prevention and Research Institute of TexasC/M Capital PartnersIppon Capital